| | Reverse Shoulder Arthroplasty: A Role DefinedThe recent resurgence in interest in reverse shoulder replacement catalyzed by innovations in prosthetic design over the last two decades in Europe has now reached North America. In a short period of time, the concept has emerged from relative obscurity to preeminence as one of the hot topics at orthopedic and shoulder specialty meetings worldwide. However, cautionary data have emerged from highly respected centers and surgeons regarding a relatively high complication and reoperation rate. It is important to critically examine our reaction to and use of such a new and complicated technology as reverse shoulder replacement. This submission provides a detailed look at the advantages and shortcomings of this technology, focusing on the indications and contraindications with the concept that these are the most important factors to consider. When performed cautiously in the patient with ideal indications, this prosthesis offers the potential of an excellent result where previously there was none. The reverse shoulder replacement should be saved for patients for whom there is no reasonable alternative. Management of glenohumeral arthritis in the rotator cuff–deficient shoulder continues to be one of the most difficult challenges facing the shoulder surgeon.1 While hemiarthroplasty remains the standard of care because of its proven durability in long-term follow-up, disadvantages include inconsistent pain relief and functional restoration.2, 3, 4, 5, 6, 7, 8 Attempts to resurface the glenoid with traditional total shoulder prostheses have resulted in premature glenoid loosening due to superior migration of the humeral prosthesis and eccentric superior loading of the glenoid component.9, 10 In the past, many constrained and semiconstrained shoulder prosthetic designs, in both traditional and reverse orientations, have been implanted in patients with rotator cuff deficiency with predominantly poor results.11, 12, 13 The 1985 design of Paul Grammont was modified and renamed “Delta” (DePuy International, Ltd., Leeds, England) and has been implanted in France since 1991 and in the United States since 2003. The Grammont design was revolutionary because of two fundamental advances. Elimination of the “neck” on the enlarged glenoid hemisphere resulted in medialization of the center of rotation to a point within the glenoid vault. The second major advance was a horizontally oriented small humeral cup covering less than half of the glenosphere.14 Resulting biomechanical advantages include decreased torque on the glenoid component, restoration of deltoid tension by lowering the humerus, and recruitment of more anterior and posterior deltoid fibers to assist in elevation and abduction, greater range of motion before implant impingement, and greater stability. Results of Hemiarthroplasty  Because of the previously mentioned failures of both nonconstrained and constrained total shoulder arthroplasty designs for cuff tear arthropathy, the current recommendations for this condition consist of either hemiarthroplasty or the reverse prosthesis. Humeral head replacement in this situation has been the standard of care based on several well done retrospective studies with mid- to long-term follow-up and acceptable results (Fig. 1).2, 3, 6, 7, 8, 9, 15 Pollock and coworkers6 were awarded the Charles S. Neer Award for their study showing improved outcome of humeral head replacement versus total shoulder arthroplasty in patients with rotator cuff deficiency. In their study, shoulders with hemiarthroplasty similar satisfaction, pain relief, and functional improvement compared with those with total shoulder arthroplasty, but those with hemiarthroplasty gained significantly greater active elevation after surgery (+52° versus +2°) as well as decreased operative time and decreased blood loss. Persistent postoperative pain remained in 2 of 19 patients at average 3 year follow-up (range 1-9 years). Arntz and coworkers9 showed, in a series of 18 shoulders, that active forward elevation improved from an average of 66° preoperatively to 109° after surgery, with 3 of 18 patients with persistent postoperative pain at average 3 year follow-up (range 2-10 years). Williams and Rockwood8 retrospectively reviewed 21 cases of hemiarthroplasty for glenohumeral arthritis with rotator cuff deficiency at average 4 year follow-up (range 2-6.6 years). Using Neer’s “Limited Goals Criteria,” they reported 86% satisfactory results, with 3 of 21 patients reporting persistent moderate pain and active elevation improving from 70° before surgery to 120° after surgery. Similar midterm results, indicating that pain generally improved, although it was unpredictable, and active elevation also improved, but rarely to the overhead level, have more recently been reported by Field and coworkers,3 Sanchez-Sotelo and coworkers,7 and Zuckerman and coworkers.15 Goldberg and coworkers2 recently reported on a series of 34 shoulders at an average of 8.5 years follow-up (range 2-16 years) that had undergone hemiarthroplasty for glenohumeral arthritis with massive rotator cuff tears. It was found that, even in the long term, 76% of shoulders were satisfied according to Neer’s limited goals criteria, and that the mean improvement in active forward elevation was 78° before surgery to 115° at early follow-up, 119° at midterm follow-up, and 108° at long-term follow-up. Interestingly, in this study, it was found that, when patients are grouped into those with preoperative active elevation of less that 90° and those with greater than 90°, the results were significantly different. The group with greater than 90° of preoperative motion had 88% satisfactory results and had significantly better function, pain relief, and higher total American Shoulder and Elbow Surgeons (ASES) scores than patients who were unable to elevate the arm 90° before surgery. Results of Reverse Arthroplasty  Because the reverse prosthesis based on the Grammont design is a more recent innovation, the length of follow-up is necessarily shorter than for hemiarthroplasty on average (Fig. 2). However, there are some well done retrospective studies with midterm follow-up that are available for comparison. Studies examining the reverse have made it clear that the results are highly dependent on the indication for surgery. For example, studies in which the indication for surgery was primary cuff tear arthropathy without previous arthroplasty, the results are better and the complications fewer than in those studies that included revision of existing arthroplasty to reverse. In the largest study focusing exclusively on cuff tear arthropathy, Sirveaux and coworkers16 reported on 80 shoulders at a mean follow-up of 44 months (range 24-97) after insertion of the Grammont prosthesis. Persistent pain remained in 4% and mean active forward elevation improved from 73° to 138°, and the constant score improved from 22.6 before surgery to 65.6 after surgery. They found that the presence of the teres minor preoperatively had a significant influence on the postoperative Constant score and particularly on postoperative external rotation. The reoperation rate was 5% in this study. Other studies focusing on reverse for cuff tear arthropathy have reported reoperation rates ranging from 0 to 13%.17, 18 In the past 2 years, major shoulder centers have reported their 3-year results with the reverse prosthesis used for multiple indications. Frankle and coworkers19 reported results of 60 shoulders at average 33 month follow-up. Indications in this study included cuff tear arthropathy, fracture, and rheumatoid arthritis, but not revision arthroplasty. Active elevation increased from 55° to 105°, ASES scores increased from 34 to 68, and the visual analog pain scale improved from 6.8 to 2.2. There was a 17% complication rate and 12% revision rate in this series. Werner and coworkers20 reported results on 58 patients followed for an average of 38 months (minimum 24 months), with indications including cuff tear arthropathy and revision arthroplasty. Active elevation improved from an average of 42° to 100°. The overall complication rate was 50% (29/58), with a 33% (19/58) reoperation rate. Twenty-one patients underwent reverse arthroplasty as a revision of a previous arthroplasty, with a higher complication rate (57%) and a higher reoperation rate (38%). Complications included hematoma formation, infection, dislocation, prosthetic loosening, nerve damage, and acromion fracture (Fig. 3). In addition, the problem of scapular notching is well known, but the long-term sequelae of this phenomenon remain unknown and could be severe in longer-term follow-up. Indications: “A Role Defined”  Multiple studies have demonstrated that hemiarthroplasty for glenohumeral arthritis with rotator cuff deficiency provides acceptable levels of pain relief and patient satisfaction with long-term durability. However, in every series there is a small percentage of patients with persistent pain, and, especially in patients with preoperative pseudoparalysis, functional improvement can be minimal. The reverse, on the other hand, often results in greater pain relief and dramatically improved active elevation, but there is a high rate of early complications and reoperations. The key to success with both of these operations is in selecting the appropriate indications. General requirements for the reverse prosthesis include a low-demand patient, typically over the age of 70, with adequate glenoid bone stock for cementless fixation, a functional deltoid muscle, and the ability to comply with postoperative instructions. Because hemiarthroplasy patients with preoperative active elevation of greater than 90° have significantly better results in terms of postoperative elevation, ASES scores, and pain relief than those with pseudoparalytic shoulders elevating less than 90°, and the complication rate for hemiarthroplasty is dramatically lower than for the reverse, it is clear that these who are able to raise their arms before surgery should undergo hemiarthroplasty. In patients with pseudoparalysis, however, a hemiarthroplasty may relieve some pain, but they may have persistent pain and will be unlikely to enjoy any significant functional gains. These patients should be counseled on the relative advantages of the reverse prosthesis but should also be aware of the risk of complications. This role for the reverse is fairly straightforward. As the surgeons comfort level grows, however, indications are often expanded. The use of a reverse arthroplasty for revision of a failed shoulder arthroplasty with a nonfunctional rotator cuff is fraught with complications. In this situation, the probability of a good outcome is poor with all currently available treatments. Hemiarthroplasty is the solution least likely to result in future reoperations and serious complications but is unlikely to improve the patient’s function significantly. A reverse arthroplasty may produce dramatic results in terms of improving function if all goes well and complications are avoided, but the risk of serious complications in this patient group is up to 50% as previously discussed. A good way of assessing the advisability of a reverse prosthesis in these situations is to ask whether the patient would be better off with a resection arthroplasty than in their current condition. If the answer is “yes,” then perhaps it is worth the significant risk to implant a reverse prosthesis, because, if it does fail, the patient may be forced to ultimately accept a resection arthroplasty. If the answer is “no,” then perhaps it would be better not to gamble on a good outcome with the reverse prosthesis and “play it safe” with a hemiarthroplasty. New potential indications are beginning to emerge, including primary treatment for badly displaced four-part proximal humerus fractures and pseudoparalysis due to massive rotator cuff tears in the absence of glenohumeral arthritis. Further study is warranted before such indications can be addressed. Conclusion  It is clear that the reverse prosthesis is an exciting new technology, with the promise of addressing the shortcomings of the gold-standard hemiarthroplasty, namely, unpredictable pain relief and failure to improve active motion in the pseudoparalytic shoulder. While enthusiasm is clearly warranted since the prosthesis offers the possibility of a good result in clinical situations in which previously there was none, expansion of indications should be done with caution. Indications are clearly the most important factor affecting results at this point. Some indications, such as pseudoparalysis combined with cuff tear arthropathy or osteoarthritis with rotator cuff deficiency, are supported by the literature as having improved clinical results with a relatively low risk of complications. Other indications, such as revision of failed arthroplasty, may be reasonable despite high complication rates as long as the patient understands the risks. Other indications will require more research before they can be recommended. Perhaps Gilles Walch stated it best during the reverse symposium at the 2006 AAOS Annual Meeting, “The best indication is when there is nothing else satisfactory to propose.” References  1. 1Neer C, Craig E, Fukuda H. Cuff-tear arthropathy. J Bone Joint Surg Am. 1983;65A:1232–1244. 2. 2Goldberg S, Rieger K, Kim H, et al: Hemiarthroplasty for shoulder arthritis with massive tears of the rotator cuff, in American Academy of Orthopaedic Surgeons Annual Meeting, 2006; Chicago, IL, p. 692-693, 2006 3. 3Field LD, Dines DM, Zabinski SJ, et al. Hemiarthroplasty of the shoulder for rotator cuff arthropathy. J Shoulder Elbow Surg. 1997;6:18–23. MEDLINE |
CrossRef
4. 4DiGiovanni J, Marra G, Park JY, et al. Hemiarthroplasty for glenohumeral arthritis with massive rotator cuff tears. Orthop Clin North Am. 1998;29:477–489. Abstract | Full Text |
Full-Text PDF (1052 KB)
|
CrossRef
5. 5Collins DN, Harryman DT. Arthroplasty for arthritis and rotator cuff deficiency. Orthop Clin North Am. 1997;28:225–239. Full Text |
Full-Text PDF (1102 KB)
|
CrossRef
6. 6Pollock RG, Deliz ED, McIlveen SJ, et al. Prosthetic replacement in rotator-cuff deficient shoulders. J Shoulder Elbow Surg. 1992;1:173–186. Abstract |
Full-Text PDF (4423 KB)
|
CrossRef
7. 7Sanchez-Sotelo J, Cofield RH, Rowland CM. Shoulder hemiarthroplasty for glenohumeral arthritis associated with severe rotator cuff deficiency. J Bone Joint Surg Am. 2001;83A:1814–1822. 8. 8Williams GR, Rockwood CA. Hemiarthroplasty in rotator cuff-deficient shoulders. J Shoulder Elbow Surg. 1996;5:362–367. Abstract |
Full-Text PDF (1479 KB)
|
CrossRef
9. 9Arntz CT, Jackins S, Matsen FA. Prosthetic replacement of the shoulder for the treatment of defects in the rotator cuff and the surface of the glenohumeral joint. J Bone Joint Surg Am. 1993;75:485–491. MEDLINE 10. 10Franklin J, Barrett W, Jackins S, et al. Glenoid loosening in total shoulder arthroplasty: association with rotator cuff deficiency. J Arthroplasty. 1988;3:39–46. Abstract |
Full-Text PDF (688 KB)
|
CrossRef
11. 11Post M, Haskell SS, Jablon M. Total shoulder replacement with a constrained prosthesis. J Bone Joint Surg Am. 1980;62:327–335. MEDLINE 12. 12Boileau P, Walch G. The three-dimensional geometry of the proximal humerus: implications for surgical technique and prosthetic design. J Bone Joint Surg Br. 1997;79:857–865.
CrossRef
13. 13Cofield RH. Status of total shoulder arthroplasty. Arch Surg. 1977;112:1088–1091. MEDLINE 14. 14Boileau P, Watkinson DJ, Hatzidakis AM, et al. Grammont reverse prosthesis: design, rationale, and biomechanics. J Shoulder Elbow Surg. 2005;14(Suppl 1):S147–S161. Abstract | Full Text |
Full-Text PDF (735 KB)
|
CrossRef
15. 15Zuckerman JD, Scott AJ, Gallagher MA. Hemiarthroplasty for cuff tear arthropathy. J Shoulder Elbow Surg. 2000;9:169–172. Abstract | Full Text |
Full-Text PDF (75 KB)
|
CrossRef
16. 16Sirveaux F, Favard L, Oudet D, et al. Grammont inverted total shoulder arthroplasty in the treatment of glenohumeral osteoarthritis with massive rupture of the cuff: results of a multicentre study of 80 shoulders. J Bone Joint Surg Br. 2004;86B:388–395. 17. 17Baulot E, Chabernaud D, Grammont PM. Results of Grammont’s inverted prosthesis in omarthritis associated with major cuff destruction (Apropos of 16 cases). Acta Orthop Belg. 1995;61(Suppl 1):112–119. 18. 18Jacobs R, Debeer P, De Smet L. Treatment of rotator cuff arthropathy with a reversed Delta shoulder prosthesis. Acta Orthop Belg. 2001;67:344–347. MEDLINE 19. 19Frankle M, Siegal S, Pupello D, et al. The reverse shoulder prosthesis for glenohumeral arthritis associated with severe rotator cuff deficiency: a minimum two-year follow-up study of sixty patients. J Bone Joint Surg Am. 2005;87:1697–1705. MEDLINE 20. 20Werner CML, Steinmann PA, Gilbart M, et al. Treatment of painful pseudoparesis due to irreparable rotator cuff dysfunction with the Delta III reverse-ball-and-socket total shoulder prosthesis. J Bone Joint Surg Am. 2005;87:1476–1486. MEDLINE ⁎ Dartmouth-Hitchcock Medical Center, Lebanon, NH. † The New York Orthopaedic Hospital, Columbia Presbyterian Medical Center, New York, NY. Address reprint requests to John-Erik Bell, MD, The New York Orthopaedic Hospital, Columbia Presbyterian Medical Center, 622 West 168th Street, PH-11, New York, NY 10032.
PII: S1045-4527(06)00070-8 doi:10.1053/j.sart.2006.11.005 © 2007 Elsevier Inc. All rights reserved. | |
|